 |
PDBsum entry 1gwb
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Blood clotting
|
PDB id
|
|
|
|
1gwb
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Blood clotting
|
 |
|
Title:
|
 |
Structure of glycoprotein 1b
|
|
Structure:
|
 |
Platelet glycoprotein ib alpha chain. Chain: a, b. Fragment: n-terminal domain, residues 16-296. Synonym: gp-ib alpha, gpiba, cd42b-alpha, cd42b. Other_details: tyr 292,294,295 modified to tyrosine-o-sulphonic acid
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606
|
|
Biol. unit:
|
 |
Monomer (from PDB file)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.245
|
R-free:
|
0.274
|
|
|
Authors:
|
 |
J.Emsley,S.Uff,K.J.M.Clemetson,J.M.Clemetson,T.Harrison
|
Key ref:
|
 |
S.Uff
et al.
(2002).
Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation.
J Biol Chem,
277,
35657-35663.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Mar-02
|
Release date:
|
06-Feb-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P07359
(GP1BA_HUMAN) -
Platelet glycoprotein Ib alpha chain from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
652 a.a.
266 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
277:35657-35663
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation.
|
|
S.Uff,
J.M.Clemetson,
T.Harrison,
K.J.Clemetson,
J.Emsley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Glycoprotein Ib (GPIb) is a platelet receptor with a critical role in mediating
the arrest of platelets at sites of vascular damage. GPIb binds to the A1 domain
of von Willebrand factor (vWF-A1) at high blood shear, initiating platelet
adhesion and contributing to the formation of a thrombus. To investigate the
molecular basis of GPIb regulation and ligand binding, we have determined the
structure of the N-terminal domain of the GPIb(alpha) chain (residues 1-279).
This structure is the first determined from the cell adhesion/signaling class of
leucine-rich repeat (LRR) proteins and reveals the topology of the
characteristic disulfide-bonded flanking regions. The fold consists of an
N-terminal beta-hairpin, eight leucine-rich repeats, a disulfide-bonded loop,
and a C-terminal anionic region. The structure also demonstrates a novel LRR
motif in the form of an M-shaped arrangement of three tandem beta-turns.
Negatively charged binding surfaces on the LRR concave face and anionic region
indicate two-step binding kinetics to vWF-A1, which can be regulated by an
unmasking mechanism involving conformational change of a key loop. Using
molecular docking of the GPIb and vWF-A1 crystal structures, we were also able
to model the GPIb.vWF-A1 complex.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Overall topology of the GPIb N-terminal
domain. Ribbon diagram of the topology viewed from the side and
a 90° rotated view facing the concave surface of the
leucine-rich repeats are shown. The three short 3[10] helices
are colored light blue, and the helix in
the C-terminal flank is colored dark blue. Convex face -strands are
colored green, and concave face -strands are
colored gray. Five expressed BSS mutations, which cause loss of
vWF binding, are shown as black balls. L57F and C65R localize to
LRR2 with L129P, A156V, and L179del localized to the LRR5, LRR6,
and LRR7 -strands
respectively. The regulatory (R)-loop is colored orange with
activating platelet-type von Willebrand disease mutations G233V
and M239V indicated as orange balls. The anionic region is
colored red with the molecular structure of the sulfated
tyrosine residues 276, 278, and 279 shown in full.
|
 |
Figure 3.
Fig. 3. Fine structure of the GPIb R-loop and
anionic region. a and b, the R-loop and -strands
from the concave face viewed from two orientations related by
90° rotation are shown. Key residues are labeled including
platelet-type von Willebrand disease mutations G233V and M239V
and the Bernard-Soulier syndrome mutation A156V. c, fine
structure of the GPIb anionic
region. Key residues in the anionic region (residues 269-279)
are indicated showing the interactions with the disulfide loop
and -turn repeat
motif from LRR8. The backbone of the anionic region is colored
red, the disulfide loop is colored dark green, and the LRR8 is
colored blue. Key hydrogen bonding/electrostatic interactions
are indicated as dotted blue lines.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
35657-35663)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.Botos,
D.M.Segal,
and
D.R.Davies
(2011).
The Structural Biology of Toll-like Receptors.
|
| |
Structure,
19,
447-459.
|
 |
|
|
|
|
 |
C.Firbas,
J.M.Siller-Matula,
and
B.Jilma
(2010).
Targeting von Willebrand factor and platelet glycoprotein Ib receptor.
|
| |
Expert Rev Cardiovasc Ther,
8,
1689-1701.
|
 |
|
|
|
|
 |
J.B.McPhee,
P.Mena,
and
J.B.Bliska
(2010).
Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence.
|
| |
Infect Immun,
78,
3529-3539.
|
 |
|
|
|
|
 |
A.L.Sørensen,
V.Rumjantseva,
S.Nayeb-Hashemi,
H.Clausen,
J.H.Hartwig,
H.H.Wandall,
and
K.M.Hoffmeister
(2009).
Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes.
|
| |
Blood,
114,
1645-1654.
|
 |
|
|
|
|
 |
P.A.McEwan,
R.K.Andrews,
and
J.Emsley
(2009).
Glycoprotein Ib{alpha} inhibitor complex structure reveals a combined steric and allosteric mechanism of von Willebrand factor antagonism.
|
| |
Blood,
114,
4883-4885.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Park,
J.Huxley-Jones,
R.P.Boot-Handford,
P.N.Bishop,
T.K.Attwood,
and
J.Bella
(2008).
LRRCE: a leucine-rich repeat cysteine capping motif unique to the chordate lineage.
|
| |
BMC Genomics,
9,
599.
|
 |
|
|
|
|
 |
J.Lou,
and
C.Zhu
(2008).
Flow induces loop-to-beta-hairpin transition on the beta-switch of platelet glycoprotein Ib alpha.
|
| |
Proc Natl Acad Sci U S A,
105,
13847-13852.
|
 |
|
|
|
|
 |
N.A.Mody,
and
M.R.King
(2008).
Platelet adhesive dynamics. Part II: high shear-induced transient aggregation via GPIbalpha-vWF-GPIbalpha bridging.
|
| |
Biophys J,
95,
2556-2574.
|
 |
|
|
|
|
 |
Q.R.Fan,
and
W.A.Hendrickson
(2008).
Comparative structural analysis of the binding domain of follicle stimulating hormone receptor.
|
| |
Proteins,
72,
393-401.
|
 |
|
|
|
|
 |
Z.Chen,
J.Lou,
C.Zhu,
and
K.Schulten
(2008).
Flow-induced structural transition in the beta-switch region of glycoprotein Ib.
|
| |
Biophys J,
95,
1303-1313.
|
 |
|
|
|
|
 |
N.Matsushima,
T.Tanaka,
P.Enkhbayar,
T.Mikami,
M.Taga,
K.Yamada,
and
Y.Kuroki
(2007).
Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors.
|
| |
BMC Genomics,
8,
124.
|
 |
|
|
|
|
 |
N.Rosenberg,
S.Lalezari,
M.Landau,
B.Shenkman,
U.Seligsohn,
and
S.Izraeli
(2007).
Trp207Gly in platelet glycoprotein Ibalpha is a novel mutation that disrupts the connection between the leucine-rich repeat domain and the disulfide loop structure and causes Bernard-Soulier syndrome.
|
| |
J Thromb Haemost,
5,
378-386.
|
 |
|
|
|
|
 |
Q.R.Fan,
and
W.A.Hendrickson
(2007).
Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor.
|
| |
Mol Cell Endocrinol,
260,
73-82.
|
 |
|
|
|
|
 |
S.Z.Luo,
X.Mo,
V.Afshar-Kharghan,
S.Srinivasan,
J.A.López,
and
R.Li
(2007).
Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet.
|
| |
Blood,
109,
603-609.
|
 |
|
|
|
|
 |
T.Huyton,
and
C.Wolberger
(2007).
The crystal structure of the tumor suppressor protein pp32 (Anp32a): structural insights into Anp32 family of proteins.
|
| |
Protein Sci,
16,
1308-1315.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Du
(2007).
Signaling and regulation of the platelet glycoprotein Ib-IX-V complex.
|
| |
Curr Opin Hematol,
14,
262-269.
|
 |
|
|
|
|
 |
A.T.Nurden,
and
P.Nurden
(2006).
Inherited disorders of platelets: an update.
|
| |
Curr Opin Hematol,
13,
157-162.
|
 |
|
|
|
|
 |
L.Federici,
A.Di Matteo,
J.Fernandez-Recio,
D.Tsernoglou,
and
F.Cervone
(2006).
Polygalacturonase inhibiting proteins: players in plant innate immunity?
|
| |
Trends Plant Sci,
11,
65-70.
|
 |
|
|
|
|
 |
M.O'Seaghdha,
C.J.van Schooten,
S.W.Kerrigan,
J.Emsley,
G.J.Silverman,
D.Cox,
P.J.Lenting,
and
T.J.Foster
(2006).
Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions.
|
| |
FEBS J,
273,
4831-4841.
|
 |
|
|
|
|
 |
S.Kunishima,
T.Imai,
M.Hamaguchi,
and
H.Saito
(2006).
Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura.
|
| |
Eur J Haematol,
76,
348-355.
|
 |
|
|
|
|
 |
V.M.Chen,
and
P.J.Hogg
(2006).
Allosteric disulfide bonds in thrombosis and thrombolysis.
|
| |
J Thromb Haemost,
4,
2533-2541.
|
 |
|
|
|
|
 |
Z.Pancer,
and
M.D.Cooper
(2006).
The evolution of adaptive immunity.
|
| |
Annu Rev Immunol,
24,
497-518.
|
 |
|
|
|
|
 |
A.T.Nurden
(2005).
Qualitative disorders of platelets and megakaryocytes.
|
| |
J Thromb Haemost,
3,
1773-1782.
|
 |
|
|
|
|
 |
J.A.López,
and
J.F.Dong
(2005).
Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation.
|
| |
Blood Coagul Fibrinolysis,
16,
S11-S16.
|
 |
|
|
|
|
 |
K.Fukuda,
T.Doggett,
I.J.Laurenzi,
R.C.Liddington,
and
T.G.Diacovo
(2005).
The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation.
|
| |
Nat Struct Mol Biol,
12,
152-159.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Arya,
A.B.Kolomeisky,
G.M.Romo,
M.A.Cruz,
J.A.López,
and
B.Anvari
(2005).
Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.
|
| |
Biophys J,
88,
4391-4401.
|
 |
|
|
|
|
 |
Y.Matsubara,
M.Murata,
T.Hayashi,
K.Suzuki,
Y.Okamura,
M.Handa,
H.Ishihara,
T.Shibano,
and
Y.Ikeda
(2005).
Platelet glycoprotein Ib alpha polymorphisms affect the interaction with von Willebrand factor under flow conditions.
|
| |
Br J Haematol,
128,
533-539.
|
 |
|
|
|
|
 |
H.Shankaran,
and
S.Neelamegham
(2004).
Hydrodynamic forces applied on intercellular bonds, soluble molecules, and cell-surface receptors.
|
| |
Biophys J,
86,
576-588.
|
 |
|
|
|
|
 |
H.Ulrichts,
J.Harsfalvi,
L.Bene,
J.Matko,
J.Vermylen,
N.Ajzenberg,
D.Baruch,
H.Deckmyn,
and
I.Tornai
(2004).
A monoclonal antibody directed against human von Willebrand factor induces type 2B-like alterations.
|
| |
J Thromb Haemost,
2,
1622-1628.
|
 |
|
|
|
|
 |
K.I.Varughese,
Z.M.Ruggeri,
and
R.Celikel
(2004).
Platinum-induced space-group transformation in crystals of the platelet glycoprotein Ib alpha N-terminal domain.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
405-411.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Vanhoorelbeke,
H.Ulrichts,
R.A.Romijn,
E.G.Huizinga,
and
H.Deckmyn
(2004).
The GPIbalpha-thrombin interaction: far from crystal clear.
|
| |
Trends Mol Med,
10,
33-39.
|
 |
|
|
|
|
 |
P.Enkhbayar,
M.Kamiya,
M.Osaki,
T.Matsumoto,
and
N.Matsushima
(2004).
Structural principles of leucine-rich repeat (LRR) proteins.
|
| |
Proteins,
54,
394-403.
|
 |
|
|
|
|
 |
P.G.Scott,
P.A.McEwan,
C.M.Dodd,
E.M.Bergmann,
P.N.Bishop,
and
J.Bella
(2004).
Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan.
|
| |
Proc Natl Acad Sci U S A,
101,
15633-15638.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Hu,
Y.Yagi,
T.Tanji,
S.Zhou,
and
Y.T.Ip
(2004).
Multimerization and interaction of Toll and Spätzle in Drosophila.
|
| |
Proc Natl Acad Sci U S A,
101,
9369-9374.
|
 |
|
|
|
|
 |
A.Di Matteo,
L.Federici,
B.Mattei,
G.Salvi,
K.A.Johnson,
C.Savino,
G.De Lorenzo,
D.Tsernoglou,
and
F.Cervone
(2003).
The crystal structure of polygalacturonase-inhibiting protein (PGIP), a leucine-rich repeat protein involved in plant defense.
|
| |
Proc Natl Acad Sci U S A,
100,
10124-10128.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Adam,
M.C.Bouton,
M.G.Huisse,
and
M.Jandrot-Perrus
(2003).
Thrombin interaction with platelet membrane glycoprotein Ib alpha.
|
| |
Trends Mol Med,
9,
461-464.
|
 |
|
|
|
|
 |
G.Borthakur,
M.A.Cruz,
J.F.Dong,
L.McIntire,
F.Li,
J.A.López,
and
P.Thiagarajan
(2003).
Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood.
|
| |
J Thromb Haemost,
1,
1288-1295.
|
 |
|
|
|
|
 |
J.E.Sadler
(2003).
Structural biology. A ménage à trois in two configurations.
|
| |
Science,
301,
177-179.
|
 |
|
|
|
|
 |
J.K.Bell,
G.E.Mullen,
C.A.Leifer,
A.Mazzoni,
D.R.Davies,
and
D.M.Segal
(2003).
Leucine-rich repeats and pathogen recognition in Toll-like receptors.
|
| |
Trends Immunol,
24,
528-533.
|
 |
|
|
|
|
 |
K.J.Clemetson
(2003).
Platelet receptors and their role in diseases.
|
| |
Clin Chem Lab Med,
41,
253-260.
|
 |
|
|
|
|
 |
M.Arya,
J.A.López,
G.M.Romo,
M.A.Cruz,
A.Kasirer-Friede,
S.J.Shattil,
and
B.Anvari
(2003).
Glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3): effects of receptor clustering and von Willebrand factor adhesion.
|
| |
J Thromb Haemost,
1,
1150-1157.
|
 |
|
|
|
|
 |
M.P.Machner,
S.Frese,
W.D.Schubert,
V.Orian-Rousseau,
E.Gherardi,
J.Wehland,
H.H.Niemann,
and
D.W.Heinz
(2003).
Aromatic amino acids at the surface of InlB are essential for host cell invasion by Listeria monocytogenes.
|
| |
Mol Microbiol,
48,
1525-1536.
|
 |
|
|
|
|
 |
R.K.Andrews,
E.E.Gardiner,
Y.Shen,
J.C.Whisstock,
and
M.C.Berndt
(2003).
Glycoprotein Ib-IX-V.
|
| |
Int J Biochem Cell Biol,
35,
1170-1174.
|
 |
|
|
|
|
 |
R.K.Andrews,
and
M.C.Berndt
(2003).
Platelet physiology: in cold blood.
|
| |
Curr Biol,
13,
R282-R284.
|
 |
|
|
|
|
 |
S.S.Smyth
(2003).
Tweezing apart von Willebrand factor-glycoprotein Ib-IX adhesive signaling.
|
| |
J Thromb Haemost,
1,
1136-1137.
|
 |
|
|
|
|
 |
Y.Matsubara,
M.Murata,
K.Sugita,
and
Y.Ikeda
(2003).
Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
|
| |
J Thromb Haemost,
1,
2198-2205.
|
 |
|
|
|
|
 |
J.E.Sadler
(2002).
Biomedicine. Contact--how platelets touch von Willebrand factor.
|
| |
Science,
297,
1128-1129.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |